INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
04/08/2026
Voltar para busca
Dado oficial do USPTO
LOPRO90
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
04/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
10
Data de depósito
24/06/2016
Data de registro
16/10/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/05/2025
Última transação
04/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
JACKSON, SHA-KARA ELOUISE
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Vascutek Limited
Representantes
Jeffrey H. Greger Roberts Mlotkowski Safran & Cole P.C.
Classificação técnica
Classes Nice
Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Surgical apparatus and instruments; medical apparatus and instruments for use in cardiovascular procedures; prosthetic vascular grafts; prosthetic endovascular grafts; stentspatches for repair and reconstruction of internal tissuecardiovascular patchespericardial patchescarotid patchesvascular prostheses; vascular prostheses; surgical implants comprising prosthetic materials; suture materials namelycardiac valves for surgical prosthesesstentsprosthetic vascular graftsvascular prosthesesprosthetic vascular graftsprosthetic endovascular graftscatheters; artificial implantspatches for repair and/or reconstruction of internal tissue; implantable medical systems consisting of stent grafts and stent graft delivery systems; implantable medical devices consisting of artificial materials; synthetic vascular grafts; synthetic endovascular grafts; synthetic surgical graft materialsvascular prostheses for the treatment of aneurysmal or occlusive arterial disease ; medical systemscardiac valves for surgical prosthesesstentsprosthetic vascular graftsvascular prosthesesprosthetic vascular graftsprosthetic endovascular graftscatheters; medical devicesimplantable medical devicesimplants consisting of artificial materialssynthetic vascular prosthesesartificial vascular graftssynthetic heart valve conduits; artificial vascular grafts; medical systems and medical devices for use in endovascular procedures; thoracic stents; thoracic stent grafts; stent grafts; stent graft systems; stent graft devices; stent graft systems and devices comprising more than one component; stent graft systems and devices comprising components of more than one stent graft; stent graft systems and devices comprising components of more than one type of stent graft; thoracic stent graft systemsconsisting of synthetic stent graftsstent delivery systemsstent graft delivery systems; thoracic stent graft devices; delivery systems for stent graft systems and stent graft devices; aneurysm repair systems consisting of catheter delivered stent graftsmedical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent graftsstent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; aneurysm repair devices; cardiac valves for surgical prostheses; cardiac valve replacement systems consisting of artificial cardiac valves; artificial heart valves; artificial heart valve conduits; synthetic cardiac patches; synthetic vascular patches; synthetic cardiovascular patches; synthetic thoracic patches; synthetic tissue patches; parts and fittings for all of the aforementioned goods; all the foregoing excluding electrosurgical probeselectrodes and power supplies for electrodescarrying cases and bags fitted for medical instruments for use by doctorsmedical bags adapted for medicalsurgical and veterinary instruments and cases fitted for medical instruments for use by doctors
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
INPC
INVALIDATION PROCESSED
04/08/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
02/01/2026
C71T
CANCELLED SECTION 71
02/05/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
16/10/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/02/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/01/2019
FIMP
FINAL DISPOSITION PROCESSED
27/01/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/01/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
16/10/2018
GPNX
NOTIFICATION PROCESSED BY IB
12/10/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/07/2018
PUBO
PUBLISHED FOR OPPOSITION
31/07/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/07/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/07/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/06/2018
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/06/2018
ALIE
ASSIGNED TO LIE
31/05/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/03/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/02/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
14/02/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
13/11/2017
GNSL
LETTER OF SUSPENSION E-MAILED
13/11/2017
CNSL
SUSPENSION LETTER WRITTEN
13/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/10/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/10/2017
ALIE
ASSIGNED TO LIE
16/10/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/10/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
24/05/2017
GNSL
LETTER OF SUSPENSION E-MAILED
24/05/2017
CNSL
SUSPENSION LETTER WRITTEN
24/05/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/05/2017
RFNT
REFUSAL PROCESSED BY IB
25/11/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/11/2016
RFRR
REFUSAL PROCESSED BY MPU
10/11/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/11/2016
CNRT
NON-FINAL ACTION WRITTEN
03/11/2016
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
27/10/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/10/2016
CNRT
NON-FINAL ACTION WRITTEN
06/10/2016
DOCK
ASSIGNED TO EXAMINER
03/10/2016
MAFR
APPLICATION FILING RECEIPT MAILED
13/09/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/09/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/09/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LOPRO90 ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.